Policy & Regulation
Analysis expands from part of the tuberculosis bacterium’s genetic information to its entire genome Identifying transmission links in drug-resistant tuberculosis to strengthen efforts to stop spread

The Korea Disease Control and Prevention Agency (KDCA) is expanding its analysis of tuberculosis bacteria from partial to whole-genome sequencing to more precisely identify transmission routes between patients.
On the 4th, the KDCA said it would overhaul its tuberculosis genotyping system to use whole-genome sequencing (WGS) to more definitively identify routes of tuberculosis transmission.
Whole-genome sequencing reads and analyzes the entire genome of the tuberculosis bacterium. About 17,000 new tuberculosis cases were reported in South Korea last year. The government aims to reduce the incidence of tuberculosis to 20 or fewer cases per 100,000 people by 2027.
Currently, when a suspected tuberculosis outbreak occurs in places such as schools and nursing homes, the KDCA analyzes the genetic relatedness of the bacteria to provide scientific evidence for identifying transmission routes. However, the current method compares only part of the tuberculosis bacterium’s genetic information, limiting its ability to identify transmission routes among patients for whom contact has not been confirmed.
The newly introduced whole-genome sequencing analyzes all approximately 4.4 million base pairs of the tuberculosis bacterium to precisely assess how similar the bacteria identified in different patients are. By detecting subtle genetic differences that were difficult to distinguish with previous analyses, the method will make it possible to more precisely identify transmission links between patients that are difficult to determine through epidemiological investigations alone.
The KDCA plans to apply whole-genome sequencing to drug-resistant tuberculosis cases with unclear transmission routes. It also plans to use accumulated genomic information to continuously analyze the spread of tuberculosis bacteria in South Korea and trends in drug-resistant tuberculosis outbreaks.
KDCA Commissioner Seung-kwan Lim said, "The introduction of whole-genome sequencing will enable more precise analysis of transmission patterns between tuberculosis patients," adding, "We hope to link the analysis results with epidemiological investigations to identify tuberculosis transmission early and use the findings to help stop its spread."

BIOBOOK TEAM
biobookmedia@biobook.co.kr
Surge in Companies Abandoning Essential Drug Production; MFDS Closes 63.8% of Cases With ‘No Action Needed’

Biotechs Sell Bread and Cosmetics Instead of Developing Drugs as Delisting Rules Distort Their Core Business

“A 30-day IND review is window dressing”: Biotech industry urges response to China’s speed

MFDS Approves First Domestically Developed GLP-1 Obesity Drug

Pharmacies to Remove ‘Warehouse’ and ‘Mart’ From Signs

Jointstem Wins in Court, but Commercialization Remains Uncertain; Shareholders File Criminal Complaint Against MFDS Chief

Peptone nears end of two-year Lilly technology evaluation…follow-on deal could be pivotal

HLB Pharmaceutical Completes 60.8 Billion Won Rights Offering, Bets on New Hyangnam Plant as Management Participation Grows

Song Young-sook sells 86 billion won stake; buyer is daughter’s one-person company — Is a second round of Hanmi control battle looming?